Year: 2021

Zai-Lab-Limited-3

Zai Lab Partner argenx Announces U.S. Food and Drug Administration (FDA) Approval of VYVGART™ (efgartigimod alfa-fcab) in Generalized Myasthenia Gravis

VYVGART is the first and only FDA-approved neonatal Fc receptor blocker 68% of anti-acetylcholine receptor (AChR) antibody positive gMG patients...

news_6

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages iQIYI, Inc. Investors to Secure Counsel Before Important January 31 Deadline in Securities Class Action – IQ

NEW YORK--(BUSINESS WIRE)--#IQ--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of iQIYI, Inc....

news_6

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Organogenesis Holdings Inc. Investors to Secure Counsel Before Important February 8 Deadline in Securities Class Action – ORGO

NEW YORK--(BUSINESS WIRE)--#ORGO--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Organogenesis Holdings...

news_6

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Alfi, Inc. Investors to Secure Counsel Before Important January 31 Deadline in Securities Class Action – ALF

NEW YORK--(BUSINESS WIRE)--#ALF--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Alfi, Inc....

news_6

ROSEN, A LEADING LAW FIRM, Encourages American Century Value Fund Investors to Secure Counsel Before Important January 10 Deadline in Securities Class Action – TWVLX, AVLIX, AVUYX, TWADX, ACLCX, AVURX, AVUGX, AVUDX

news_6

ROSEN, A LEADING LAW FIRM, Encourages Reconnaissance Energy Africa Ltd. f/k/a Lund Enterprises Corp. Investors to Secure Counsel Before Important December 27 Deadline in Securities Class Action Commended by the Firm – RECAF, LGDOF